oxidized low density lipoprotein ldl potent atherogenic lipoprotein shown cause alteration various endothelial functions examined effect oxidized ldl cofactor activity protein c activation expression thrombomodulin tm cell surface antithrombotic glycoprotein cultured human umbilical vein endothelial cells oxidized ldl prepared irradiation ldl ultraviolet light did directly affect cofactor activity isolated tm exposure cells oxidized ldl native ldl acetylated ldl reduced tm cofactor activity parallel antigen levels cell surface concentration manner tm mrna levels reduced prior decrease tm antigen levels NUMBER control levels NUMBER h treatment cells oxidized ldl apparent time NUMBER h tm mrna oxidized cells did significantly differ NUMBER h control cells cells coincubated transcriptional inhibitor treatment cells bafilomycin a1 inhibitor proton pump lysosomes inhibited intracellular degradation ldl prevented mrna cell surface tm antigen levels caused oxidized ldl inhibitor molecule oxidized ldl shown lipid organic solvent extracts NUMBER cholesterol equivalent concentration lipids NUMBER oxidized ldl oxidized ldl inhibited expression tm antigen nearly extent oxidized ldl water extracts did affect tm expression cells results suggested tm endothelial cells exposed oxidized ldl resulted inhibition transcription mediated lysosomal degradation oxidized ldl lipid component ldl active species decrease tm expression surface endothelial cells contribute promote thrombosis atherosclerotic lesions thrombin dependent NUMBER nm NUMBER NUMBER oxidation time dependent half life ldl treated NUMBER dichloro NUMBER beta d ribofuranosylbenzimidazole regulations regulation microg ml t1 NUMBER t1 NUMBER mg ml microg ml